Company intelligence / Profile preview

ZyVet Animal Health

Pennington, NJ, USA

Ownership: Private
Development stage: Other

Overview

ZyVet Animal Health has commercialized an expanding portfolio of FDA-approved generic medications for companion animals, including first-to-market generics for canine urinary incontinence and chronic heart conditions, supporting cost-effective veterinary care with validated clinical efficacy

Therapeutic areas: NephrologyCardiovascularImmunologyRheumatologyInfectious DiseasesPsychiatry
Modalities: Small molecule
Industry: Veterinary

Partnerships

Relationship with Zydus Lifesciences for manufacturing/R&D

Beyond the preview

Go deeper on ZyVet Animal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZyVet Animal Health.

Explore the full profile